Falutz J, Mamputu JC, Potvin D, et al.: Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: A pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Although BPC-157 is not classified as a hormone, steroid or SARM, it has gained a reputation because researchers frequently explore its impact on biological processes related to repair, inflammation and physical resilience
Laboratory studies further underscore its potential for improving gut health, spinal cord injury recovery, chronic pain management, and cognitive function, suggesting possible future clinical applications
Well work with you to create a customized treatment plan that helps you feel your best inside and out
Vascular Pharmacology, 106, 54-66
A BPC-157 cycle length depends on why it is being used and how the patient responds during treatment